KRAS and colonic neoplasm: To provide a control for the experiment, HCT-116 (colon cancer) cells, another KRAS G13D mutant cancer cell line, and both MCF-7 (breast cancer) and HT-29 (colon cancer) cells, which are KRAS wild-type cancer cell lines, were used.